Results 201 to 210 of about 756,756 (215)

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

The Pediatric Infectious Disease Journal, 1996
BACKGROUND Streptococcus pneumoniae is the most common cause of invasive bacterial disease and otitis media in infants and young children. Licensed pneumococcal polysaccharide vaccines are not reliably immunogenic in children younger than 2 years of age;
K. O'Brien, M. Steinhoff, K. Edwards, H. Keyserling, Mary Lou Thoms, D. Madore   +5 more
semanticscholar   +1 more source

Use of pneumococcal polysaccharide vaccines: no simple answers.

Journal of Infection, 2003
Control of pneumococcal disease by vaccination with capsular polysaccharide has been investigated and promoted with variable enthusiasm for the past 90 years.
N. French
semanticscholar   +1 more source

Pneumococcal disease and its prevention with polyvalent pneumococcal polysaccharide vaccines--a review.

Australian and New Zealand Journal of Medicine, 1979
Polyvalent pneumococcal polysaccharide vaccines have been shown to be safe, immunogenic and efficacious and are becoming available for use in patients at high risk of developing pneumococcal infections.
R. Douglas, I. Riley
semanticscholar   +1 more source

Pneumococcal polysaccharide vaccines.

Reviews of Infectious Diseases, 1989
Pneumococcal infections are major causes of morbidity and mortality in children throughout the world. For this reason and because of the increasingly frequent isolation of multiply resistant pneumococci of the serotypes most often causing infection in ...
R. Austrian
semanticscholar   +1 more source

Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease.

Annals of Internal Medicine, 1986
Overwhelming sepsis is a serious complication of staging splenectomy in Hodgkin's disease. To define an optimal immunization strategy, 51 patients received 14-valent pneumococcal, Haemophilus influenzae type b, and meningococcal group C vaccines before ...
G. Siber, C. Gorham, P. Martin, J. Corkery, G. Schiffman   +4 more
semanticscholar   +1 more source

Factors influencing immunogenicity and safety of two Haemophilus influenzae type b polysaccharide vaccines in children 18 and 24 months of age.

The Pediatric Infectious Disease Journal, 1987
The purpose of this study was to evaluate differences in the safety and immunogenicity of Haemophilus influenzae type b (Hib) capsular polysaccharide vaccine produced by two manufacturers (Connaught and Praxis) in children 18 and 24 months of age. Eighty-
D. Greenberg, J. Ward, K. Burkart, P. Christenson, L. Guravitz, S. Marcy   +5 more
semanticscholar   +1 more source

Safety of Hepatitis B, Pneumococcal Polysaccharide and Meningococcal Polysaccharide Vaccines in Pregnancy

Drug Safety, 2012
M. Makris, K. Polyzos, M. Mavros, S. Athanasiou, P. Rafailidis, M. Falagas   +5 more
semanticscholar   +1 more source

Bacterial Polysaccharide Vaccines

, 2011
R. Austrian
semanticscholar   +1 more source

Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine, 1978
J. Borgoño, A. Mclean, P. Vella, A. Woodhour, I. Canepa, Wallace L. Davidson, M. Hilleman   +6 more
semanticscholar   +1 more source

Immunologic response of man to group B meningococcal polysaccharide vaccines.

Journal of Infectious Diseases, 1972
F. Wyle, M. Artenstein, B. Brandt, E. Tramont, D. Kasper, P. Altieri, S. Berman, J. Lowenthal   +7 more
semanticscholar   +1 more source